Aurora, CONCT06013579Now EnrollingIRB Ready

HIV Infections Clinical Trial in Aurora, CO

Access cutting-edge hiv infections treatment through this clinical trial at a research site in Aurora. Study-provided care at no cost to qualified participants.

Sponsored by University of Alabama at Birmingham

Quick Self-Assessment

See if you qualify for this Aurora location

Preparing your pre-screening questions…

Expert Care in Aurora

Access hiv infections specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hiv infections treatment provided free

Apply for This Aurora Location

Check if you qualify for this hiv infections clinical trial in Aurora, CO

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Aurora

    Convenient for CO residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Aurora site if eligible
  4. 4Begin participation

About This HIV Infections Study in Aurora

People aging with HIV are at higher risk for Alzheimer's disease and related dementias, and although physical activity is a promising target to mitigate such risk, this population engages in low levels of physical activity. Few studies have tested cognitive effects of exercise interventions or examined mechanisms of adherence to long-term exercise among diverse samples of midlife and older people with HIV. The current study will leverage an existing R01 to address these gaps and provide implications for development of personalized approaches for the treatment and prevention of cognitive impairment and dementia in older people with HIV.

Sponsor: University of Alabama at Birmingham

Who Can Participate

Inclusion Criteria

Confirmed HIV
Sedentary lifestyle, defined as self-reported PA that breaks a sweat \<3 days/week, with no regular resistance exercise for 3 months preceding study;
Fatigued (≥2.0 on either of the first two screening items on the HIV-Related Fatigue Scale)
On a current, contemporary ART regimen for \>=12 months;
HIV-1 RNA \<200 copies/mL in the past 12 months (assessed via medical records)
Willing to engage in a supervised exercise program 3 times/week for 4 months
Cell phone or email to accept messages
Weight \<450 lbs
Medical clearance by study healthcare professional

Exclusion Criteria

Weight over 450 pounds
Use of sex hormone therapy, if on for ≤3 months (stable doses for \>3 months will be permitted)
Use of other hormone replacement, if on for ≤ 3 months (stable doses \>3 months will be permitted)
Anemia (Hemoglobin ≤9 g/dL for women or ≤10 g/dL for men) due to contribution to fatigue,
Diagnosis of mitochondrial disease,
Active substance abuse or other factors that could prevent compliance or safety with study visits, at the discretion of the site investigator,
Reasons for medical exclusion, as determined by Nurse Practioner:
Uncontrolled hypertension defined as resting systolic blood pressure \>150 mmHg or diastolic blood pressure \>90 mmHg; participants who do not meet these criteria at first screening will be reevaluated, including follow-up evaluation by their primary care provider with initiation or adjustment of anti-hypertensive medications,
Unstable ischemic heart disease (e.g., angina, ST segment depression) or serious arrhythmias at rest or during the graded exercise test without negative follow-up evaluation will be cause for exclusion; follow-up evaluation must include diagnostic testing (e.g., thallium stress test) with interpretation by a cardiologist,
New York Heart Association Class III or IV congestive heart failure, clinically significant aortic stenosis, uncontrolled angina, or uncontrolled arrhythmia,
Pulmonary disease requiring the use of supplemental oxygen at rest or with physical exertion,
Malignancy requiring chemotherapy or radiation therapy within 24 weeks prior to enrollment,
Poorly controlled diabetes, as evidenced by hemoglobin A1c \> 8.5, documented within 6 months of study visit or current use of insulin,
Surgery/trauma/injury/fracture within 24 weeks prior to enrollment that, in the opinion of the study clinician, may impact a subject's baseline functional testing and ability to exercise,
Balance impairments that may impact functional testing and ability to safely exercise as reported by the participant or in their medical record,
Orthopedic problems (e.g., severe osteoarthritis, rheumatoid arthritis) that greatly limit the ability to perform moderate intensity resistance exercise (e.g., unable to be properly positioned in exercise equipment or to have severely restricted range of motion even after modifications have been made),
Persons who, in the judgment of the study clinician, appear to have unstable health or are incapable of safely participating in the exercise intervention.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Aurora?

Yes, this clinical trial (NCT06013579) has an active research site in Aurora, CO that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

HIV Infections Treatment Options in Aurora, CO

If you're searching for hiv infections treatment options in Aurora, CO, this clinical trial (NCT06013579) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Aurora research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hiv infections specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hiv infections clinical trials near you to find additional studies recruiting in your area.

More HIV AIDS Trials in Aurora, CO

See all hiv aids clinical trials recruiting in Aurora — not just this study.

Browse HIV AIDS Trials in Aurora

Browse More Trials by Condition

Ready to Join in Aurora?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Aurora, CO